info icon

This is a non-core endpoint: only basic statistics are computed.

Arenaviral haemorrhagic fever

AB1_ARENAVIRAL_FEVER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 A96
  • Cause of death: ICD-10 A96

2 out of 7 registries used, show all original rules.

7

4. Check minimum number of events

None

7

5. Include endpoints

None

7

6. Filter based on genotype QC (FinnGen only)

7

Control definitions (FinnGen only)

Control exclude
AB1_ARTHROPOD

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 66 30 35
Only index persons 58 28 30
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 60.81 61.85 59.70
Only index persons 60.33 61.85 58.91

-FinnGen-

Key figures

All Female Male
Number of individuals 7 - -
Unadjusted period prevalence (%) 0.00 - -
Median age at first event (years) 60.49 - -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7
59
+∞
0.23
6.0
5.2
mmol/l
4.8
4.6
—
7
53
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7
59
+∞
0.23
6.6
5.9
mmol/l
3.1
2.8
—
7
52
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7
59
+∞
0.23
5.4
5.1
mmol/l
1.2
1.4
—
7
52
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
10
0.00
0.23
0.0
3.7
—
11.2
—
0
10
(3022145) Colonoscopy Study observation
0
10
0.00
0.23
0.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7
60
+∞
0.23
27.1
19.0
ml/min/173m2
66.3
77.5
—
7
50
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7
58
+∞
0.23
5.0
4.7
mmol/l
1.2
1.3
—
7
51
(3025941) Bacteria identified in Stool by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
2.6
—
0
6
(4010399)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(4035726)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.2
—
22.6
—
0
5
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
25.1
—
0
5
(3019225) pH of Specimen
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
7
63
+∞
0.00
26.9
16.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
38.2
—
0
6

Mortality – FinRegistry

Association

Association between endpoint AB1_ARENAVIRAL_FEVER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_ARENAVIRAL_FEVER.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: AB1_ARENAVIRAL_FEVER – Arenaviral haemorrhagic fever

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data